As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilars and biologics will likely increase at 7.6% CAGR ...

ADMA Biologics ADMA will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement. Analysts anticipate ADMA Biologics to ...

Montaigu-Vendée, France, May 6, 2025 ─ Clean Biologics, an international group providing services to the biopharmaceutical industry, today announces the appointment of Laurent Claisse as chief ...

Although biologics are usually given by injection or intravenous infusion, oral formulations might be possible. In general, oral drugs offer many benefits, from simplified distribution to overall ...

As office space, it was previously used by Altus Biologics of Texas and the local Vertex Pharmaceuticals. Residents, businesses or nonprofits in the city with questions can email [email protected] or ...

GDAŃSK, Poland and SHANGHAI, April 16, 2025 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, is pleased to announce a strategic cooperation ...

STAMFORD, Conn., April 16, 2025--(BUSINESS WIRE)--Altus Power, Inc. ("Altus Power" or the "Company") (NYSE: AMPS), a leading commercial-scale provider of clean ...

The U.S. Food and Drug Administration (U.S. FDA) has approved Biocon Biologics’ Jobevne (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous use. JOBEVNE, a recombinant humanized ...

YOKOHAMA, Japan & SEATTLE--(BUSINESS WIRE)--AGC Biologics, your friendly CDMO expert, today announced a strategic decision about the large-scale single-use technology it will use at its new ...

Biologics targeting IL-12, IL-23, or IL-17 are linked to lower infection risk in older adults with psoriatic disease compared to other systemic treatments. The study utilized Ontario's health ...

Altus Power agrees to be acquired by TPG Rise Climate for $5 per share, valuing the company at $2.2B, a 66% premium. The deal, expected to close by Q2 2025, will transition Altus Power to a ...

STAMFORD, Conn.--(BUSINESS WIRE)--Altus Power, Inc. (“Altus Power” or the “Company”) (NYSE: AMPS), the largest owner of commercial-scale solar in the US, today announced it has entered ...